176 related articles for article (PubMed ID: 17045703)
1. alpha-Amino acid derivatives as proton pump inhibitors and potent anti-ulcer agents.
Sharma P; Singh S; Siddiqui TI; Singh VS; Kundu B; Prathipati P; Saxena AK; Dikshit DK; Rastogi L; Dixit C; Gupta MB; Patnaik GK; Dikshit M
Eur J Med Chem; 2007 Mar; 42(3):386-93. PubMed ID: 17045703
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
Ito K; Kinoshita K; Tomizawa A; Inaba F; Morikawa-Inomata Y; Makino M; Tabata K; Shibakawa N
J Pharmacol Exp Ther; 2007 Oct; 323(1):308-17. PubMed ID: 17630360
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a novel pyrrole derivative 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine fumarate (TAK-438) as a potassium-competitive acid blocker (P-CAB).
Arikawa Y; Nishida H; Kurasawa O; Hasuoka A; Hirase K; Inatomi N; Hori Y; Matsukawa J; Imanishi A; Kondo M; Tarui N; Hamada T; Takagi T; Takeuchi T; Kajino M
J Med Chem; 2012 May; 55(9):4446-56. PubMed ID: 22512618
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS
J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446
[TBL] [Abstract][Full Text] [Related]
5. [Proton pump inhibitors].
Schubert-Zsilavecz M; Stark H
Pharm Unserer Zeit; 2005; 34(3):194-9. PubMed ID: 15940951
[No Abstract] [Full Text] [Related]
6. Synthesis of novel 2-[2-(substituted amino)phenethyl]-1 H-benzimidazoles; 3,4-dihydro and 1,2,3,4,-tetrahydropyrimido[1,6-a]-benzimidazoles as potential antiulcer agents.
Shafik RM; El-Din SA; Eshba NH; El-Hawash SA; Desheesh MA; Abdel-Aty AS; Ashour HM
Pharmazie; 2004 Dec; 59(12):899-905. PubMed ID: 15638075
[TBL] [Abstract][Full Text] [Related]
7. N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide (PF-03716556), a novel, potent, and selective acid pump antagonist for the treatment of gastroesophageal reflux disease.
Mori H; Tonai-Kachi H; Ochi Y; Taniguchi Y; Ohshiro H; Takahashi N; Aihara T; Hirao A; Kato T; Sakakibara M; Kurebayashi Y
J Pharmacol Exp Ther; 2009 Feb; 328(2):671-9. PubMed ID: 18981288
[TBL] [Abstract][Full Text] [Related]
8. Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors.
Shin JM; Cho YM; Sachs G
J Am Chem Soc; 2004 Jun; 126(25):7800-11. PubMed ID: 15212527
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the gastric H+,K+ -ATPase by plectrinone A, a diterpenoid isolated from Plectranthus barbatus Andrews.
Schultz C; Bossolani MP; Torres LM; Lima-Landman MT; Lapa AJ; Souccar C
J Ethnopharmacol; 2007 Apr; 111(1):1-7. PubMed ID: 17166678
[TBL] [Abstract][Full Text] [Related]
10. Anti-ulcerogenic and proton pump (H+, K+ ATPase) inhibitory activity of Kolaviron from Garcinia kola Heckel in rodents.
Onasanwo SA; Singh N; Olaleye SB; Palit G
Indian J Exp Biol; 2011 Jun; 49(6):461-8. PubMed ID: 21702226
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of gastric H+, K+-ATPase by 3-amino-5-methyl-2-(2-methyl-3-thienyl)imidazo[1,2-a]thieno[3,2-c]pyrid ine, SPI-447.
Ushiro T; Tsukimi Y; Tanaka H
Jpn J Pharmacol; 1997 Nov; 75(3):303-6. PubMed ID: 9434264
[TBL] [Abstract][Full Text] [Related]
12. Omeprazole has a dual mechanism of action: it inhibits both H(+)K(+)ATPase and gastric mucosa carbonic anhydrase enzyme in humans (in vitro and in vivo experiments).
Puscas I; Coltau M; Baican M; Domuta G
J Pharmacol Exp Ther; 1999 Aug; 290(2):530-4. PubMed ID: 10411559
[TBL] [Abstract][Full Text] [Related]
13. L-type amino acids stimulate gastric acid secretion by activation of the calcium-sensing receptor in parietal cells.
Busque SM; Kerstetter JE; Geibel JP; Insogna K
Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G664-9. PubMed ID: 15961860
[TBL] [Abstract][Full Text] [Related]
14. In vivo inhibition of gastric acid secretion by the aqueous extract of Scoparia dulcis L. in rodents.
MesÃa-Vela S; Bielavsky M; Torres LM; Freire SM; Lima-Landman MT; Souccar C; Lapa AJ
J Ethnopharmacol; 2007 May; 111(2):403-8. PubMed ID: 17300892
[TBL] [Abstract][Full Text] [Related]
15. Interferon-inducer polyriboinosinic-polyribocytidylic acid: a potent anti-gastric ulcer agent and inhibitor of the gastric proton pump in rats.
Nath C; Rastogi L; Dikshit M; Patnaik GK; Saxena RC; Gupta MB
Clin Exp Pharmacol Physiol; 1998; 25(7-8):564-7. PubMed ID: 9673429
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacology of proton pump inhibitors].
Klotz U
Pharm Unserer Zeit; 2005; 34(3):200-4. PubMed ID: 15940952
[No Abstract] [Full Text] [Related]
17. tert-Butyl 1,5-bis(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)-1,5-dioxopentan-2-ylcarbamate urea/thiourea derivatives as potent H+/K(+)-ATPase inhibitors.
Sharma A; Suhas R; Chandana KV; Banu SH; Channe Gowda D
Bioorg Med Chem Lett; 2013 Jul; 23(14):4096-8. PubMed ID: 23756367
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and pharmacological properties of a new proton pump inhibitor, 2-amino-4,5-dihydropyrido[1,2-a]thiazolo [5,4-g] benzimidazole (YJA20379-5).
Sohn SK; Chang MS; Chung YK; Kim KB; Wook TW; Kim SG; Choi WS
Arch Pharm Res; 1998 Jun; 21(3):241-7. PubMed ID: 9875438
[TBL] [Abstract][Full Text] [Related]
19. Quinoxaline chemistry. Part 6--Synthesis and evaluation of antiulcer and gastroprotective activity of 2-[arylmethylmercapto-, arylmethylsulfinyl-, piperazinyl-3-R-substituted]quinoxalines.
Piras S; Loriga M; Paglietti G; Demontis MP; Varoni MV; Fattaccio MC; Anania V
Farmaco; 1996; 51(8-9):569-77. PubMed ID: 8930110
[TBL] [Abstract][Full Text] [Related]
20. Review article: the clinical pharmacology of proton pump inhibitors.
Sachs G; Shin JM; Howden CW
Aliment Pharmacol Ther; 2006 Jun; 23 Suppl 2():2-8. PubMed ID: 16700898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
